1295 related articles for article (PubMed ID: 25850553)
1. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.
Takebe N; Miele L; Harris PJ; Jeong W; Bando H; Kahn M; Yang SX; Ivy SP
Nat Rev Clin Oncol; 2015 Aug; 12(8):445-64. PubMed ID: 25850553
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic.
Laranjeira AB; Yang SX
Expert Opin Drug Discov; 2016 Nov; 11(11):1071-1080. PubMed ID: 27626707
[TBL] [Abstract][Full Text] [Related]
3. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.
Takebe N; Harris PJ; Warren RQ; Ivy SP
Nat Rev Clin Oncol; 2011 Feb; 8(2):97-106. PubMed ID: 21151206
[TBL] [Abstract][Full Text] [Related]
4. Targeting stem cell signaling pathways for drug discovery: advances in the Notch and Wnt pathways.
An SM; Ding Q; Zhang J; Xie J; Li L
Sci China Life Sci; 2014 Jun; 57(6):575-80. PubMed ID: 24829106
[TBL] [Abstract][Full Text] [Related]
5. Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways.
Oren O; Smith BD
Stem Cell Rev Rep; 2017 Feb; 13(1):17-23. PubMed ID: 27730468
[TBL] [Abstract][Full Text] [Related]
6. Targeting pancreatic cancer stem cells for cancer therapy.
Xia J; Chen C; Chen Z; Miele L; Sarkar FH; Wang Z
Biochim Biophys Acta; 2012 Dec; 1826(2):385-99. PubMed ID: 22728049
[TBL] [Abstract][Full Text] [Related]
7. [Novel signal transduction pathways: the molecular basis for targeted cancer therapies in Hedgehog/Notch/Wnt pathway].
Shimizu T; Nakagawa K
Nihon Rinsho; 2015 Aug; 73(8):1342-8. PubMed ID: 26281688
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review.
Shukla G; Khera HK; Srivastava AK; Khare P; Patidar R; Saxena R
Curr Stem Cell Res Ther; 2017; 12(3):207-224. PubMed ID: 27804866
[TBL] [Abstract][Full Text] [Related]
9. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
Clara JA; Monge C; Yang Y; Takebe N
Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
11. Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis.
Beyer C; Dees C; Distler JH
Arch Dermatol Res; 2013 Jan; 305(1):1-8. PubMed ID: 23208311
[TBL] [Abstract][Full Text] [Related]
12. Targeting Notch to target cancer stem cells.
Pannuti A; Foreman K; Rizzo P; Osipo C; Golde T; Osborne B; Miele L
Clin Cancer Res; 2010 Jun; 16(12):3141-52. PubMed ID: 20530696
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer.
Brechbiel J; Miller-Moslin K; Adjei AA
Cancer Treat Rev; 2014 Jul; 40(6):750-9. PubMed ID: 24613036
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors.
Krishnamurthy N; Kurzrock R
Cancer Treat Rev; 2018 Jan; 62():50-60. PubMed ID: 29169144
[TBL] [Abstract][Full Text] [Related]
15. Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers.
Martins-Neves SR; Sampaio-Ribeiro G; Gomes CMF
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176108
[TBL] [Abstract][Full Text] [Related]
16. Novel Small Molecule Inhibitors of Cancer Stem Cell Signaling Pathways.
Abetov D; Mustapova Z; Saliev T; Bulanin D; Batyrbekov K; Gilman CP
Stem Cell Rev Rep; 2015 Dec; 11(6):909-18. PubMed ID: 26210995
[TBL] [Abstract][Full Text] [Related]
17. Eradicating Cancer Stem Cells: Concepts, Issues, and Challenges.
Kaur G; Sharma P; Dogra N; Singh S
Curr Treat Options Oncol; 2018 Mar; 19(4):20. PubMed ID: 29556842
[TBL] [Abstract][Full Text] [Related]
18. Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability.
Distler A; Lang V; Del Vecchio T; Huang J; Zhang Y; Beyer C; Lin NY; Palumbo-Zerr K; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2014 Jun; 73(6):1264-8. PubMed ID: 24445254
[TBL] [Abstract][Full Text] [Related]
19. Drug discovery approaches to target Wnt signaling in cancer stem cells.
Curtin JC; Lorenzi MV
Oncotarget; 2010 Nov; 1(7):563-577. PubMed ID: 21317452
[TBL] [Abstract][Full Text] [Related]
20. Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics.
Bhal S; Kundu CN
Med Oncol; 2023 Jan; 40(2):82. PubMed ID: 36662310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
